Aynun Begum

Dr. Aynun Begum is a founder and Chief Executive Officer (CEO) of NeyroblastGX. She earned her Ph.D. and did postdoctoral training at the University of Tokushima, Japan, and the Institute of National Research on Agronomique, France, on blood flow microcirculation and polyphenol chemistry, respectively. Dr. Begum completed her extensive postgraduate research study at the University of California, Los Angeles (UCLA), on the neurobiology of disease (Alzheimer’s disease). She has also worked as a senior stem cell specialist at the University of California, Riverside (UCR), and at the Western University of Health Sciences (WUHS) on generating human pluripotent stem cell-derived human organoids. Later in her career, as a principal investigator (Senior Scientist) in InnoSense LLC, she was devoted to developing Alzheimer’s diagnostic and theranostic products, including biomaterial fabrication and encapsulation. She has received funding from NIH (National Institute of Health Sciences), NIH-NIA, the Defense Health Agency, and the Navy.